ResearchMoz

Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth

GBI Research
Published Date » 2011-07-15
No. Of Pages » 118

GBI Researchs report, Neurology Devices Market to 2017 - High Potential for Usage of Neurostimulation Devices in Multiple Neurological Disorders to Drive Market Growth provides key data, information and analysis on the global neurology devices market. The report provides market landscape, competitive landscape and market trends information on five neurology devices market categories CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. 

The report also reviews the competitive landscape and a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the neurology devices market during the past four years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Market size and company share data for five neurology devices market categories CSF management, neurosurgical products, neurostimulation devices, interventional neurology, and neurological diagnostic equipment.
  • Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010 has been given for all categories.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within the endoscopy devices market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
  • Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG and Cadwell Laboratories, Inc.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the neurology devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Whats the next big thing in the neurology devices market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global neurology devices market and the factors shaping it.
Table of Contents

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 10
2.1 GBI Research Guidance 10

3 Global Neurology Devices Market Characterization 11
3.1 Global Neurology Devices Market, Revenue ($m), 20032010 11
3.2 Global Neurology Devices Market, Revenue Forecast ($m), 20102017 12
3.3 Global Neurology Devices Market, Key Trends 13
3.3.1 Neurostimulation Devices Segment Holds Significant Potential for Venture Capitalists 13
3.3.2 Innovative Therapies to be a Mainstay in the Neurology Devices Market 13
3.3.3 Robotic Neurosurgery is Improving Accuracy at a Microscopic Level 14
3.3.4 Increasing Demand for Minimally Invasive Surgery is Positively Impacting the Interventional Neurology Market 15
3.4 Global Neurology Devices Market, Market Dynamics 15
3.4.1 Market Drivers 16
3.4.2 Market Restraints 17
3.5 Global Neurology Devices Market, Key Company Share (%), 2010 19

4 Global Neurology Devices Market - Category Analysis and Forecasts 20
4.1 Neurology Devices 20
4.2 CSF Management 20
4.2.1 CSF Management Market, Global, Revenue ($m), 20032010 21
4.2.2 CSF Management Market, Global, Revenue Forecast ($m), 20102017 22
4.2.3 CSF Management - Market Dynamics 23
4.2.4 Market Drivers 23
4.2.5 Market Restraints 24
4.2.6 CSF Management Market, Global, Company Share (%), 2010 25
4.3 Neurosurgical Products 26
4.3.1 Neurosurgical Products Market, Global, Revenue ($m), 20032010 26
4.3.2 Neurosurgical Products Market, Global, Revenue Forecast ($m), 20102017 27
4.3.3 Neurosurgical Products Market Dynamics 28
4.3.4 Market Drivers 28
4.3.5 Market Restraints 29
4.3.6 Neurosurgical Products Market, Global, Company Share (%), 2010 30
4.4 Neurostimulation Devices 31
4.4.1 Neurostimulation Devices Market, Global, Revenue ($m), 20032010 32
4.4.2 Neurostimulation Devices Market, Global, Revenue Forecasts ($m), 20102017 33
4.4.3 Neurostimulation Devices Market Dynamics 34
4.4.4 Market Drivers 35
4.4.5 Market Restraints 39
4.4.6 Neurostimulation Device Market, Global, Company Shares (%), 2010 40
4.4.7 Interventional Neurology Market, Global, Revenue ($m), 20032010 42
4.4.8 Interventional Neurology Market, Global, Revenue Forecasts ($m), 20102017 43
4.4.9 Interventional Neurology: Market Dynamics 44
4.4.10 Market Drivers 44
4.4.11 Market Restraints 45
4.4.12 Interventional Neurology Market, Global, Company Shares (%), 2010 46
4.4.13 Neurological Diagnostic Equipment Market, Global, Revenue ($m), 20032010 47
4.4.14 Neurological Diagnostic Equipment Market, Global, Revenue Forecasts ($m), 20102017 48
4.4.15 Neurological Diagnostic Equipment: Market Dynamics 49
4.4.16 Market Drivers 49
4.4.17 Market Restraints 50
4.4.18 Neurological Diagnostic Equipment Market, Global, Company Shares (%), 2010 51

5 Global Neurology Devices Market - Country Analysis and Forecasts 52
5.1 Neurology Devices Market: Cross Country Analysis 52
5.2 Revenue Forecasts, By Country, 2003-2017 53
5.2.1 Neurology Devices Market, the US, Revenue ($m), 20032010 53
5.2.2 Neurology Devices Market, the US, Revenue ($m), 20102017 54
5.2.3 Neurology Devices Market, Canada, Revenue ($m), 20032010 55
5.2.4 Neurology Devices Market, Canada, Revenue ($m), 20102017 56
5.2.5 Neurology Devices Market, the UK, Revenue ($m), 20032010 57
5.2.6 Neurology Devices Market, the UK, Revenue ($m), 20102017 58
5.2.7 Neurology Devices Market, Germany, Revenue ($m), 20032010 59
5.2.8 Neurology Devices Market, Germany, Revenue ($m), 20102017 60
5.2.9 Neurology Devices Market, France, Revenue ($m), 20032010 61
5.2.10 Neurology Devices Market, France, Revenue ($m), 20102017 62
5.2.11 Neurology Devices Market, Italy, Revenue ($m), 20032010 63
5.2.12 Neurology Devices Market, Italy, Revenue ($m), 20102017 64
5.2.13 Neurology Devices Market, Spain, Revenue ($m), 20032010 65
5.2.14 Neurology Devices Market, Spain, Revenue ($m), 20102017 66
5.2.15 Neurology Devices Market, Japan, Revenue ($m), 20032010 67
5.2.16 Neurology Devices Market, Japan, Revenue ($m), 20102017 68
5.2.17 Neurology Devices Market, China, Revenue ($m), 20032010 69
5.2.18 Neurology Devices Market, China, Revenue ($m), 20102017 70
5.2.19 Neurology Devices Market, India, Revenue ($m), 20032010 71
5.2.20 Neurology Devices Market, India, Revenue ($m), 20102017 72
5.2.21 Neurology Devices Market, Australia, Revenue ($m), 20032010 73
5.2.22 Neurology Devices Market, Australia, Revenue ($m), 20102017 74
5.2.23 Neurology Devices Market, Brazil, Revenue ($m), 20032010 75
5.2.24 Neurology Devices Market, Brazil, Revenue ($m), 20102017 76

6 Global Neurology Devices Market - Competitive Assessment 77
6.1 Neurology Devices Market Opportunities and Risk Evaluation 77
6.2 Medtronic, Inc. 79
6.2.1 Business Overview 80
6.2.2 Key Products 80
6.3 Boston Scientific Corporation (Neurovascular Portfolio Acquired by Stryker) 82
6.3.1 Business Overview 82
6.3.2 Key Products 82
6.4 St. Jude Medical, Inc 84
6.4.1 Business Overview 84
6.4.2 Key Products 85
6.5 Integra LifeSciences Holdings Corporation 86
6.5.1 Business Overview 86
6.5.2 Key Products 86
6.6 B. Braun Melsungen AG 89
6.6.1 Business Overview 89
6.7 Cadwell Laboratories, Inc. 90
6.7.1 Business Overview 90
6.7.2 Key Products 90

7 Global Neurology Devices Market - Product Pipeline Analysis 92
7.1 Neurology Devices - Pipeline Products Summary 92
7.2 Neurostimulation Devices 93
7.2.1 Neurostimulation Devices: List of Pipeline Products 93
7.2.2 Neurostimulation Devices: Profiles of Key Pipeline Products 98
7.3 Interventional Neurology 100
7.3.1 Interventional Neurology: List of Pipeline Products 100
7.3.2 Interventional Neurology: Profiles of Key Pipeline Products 102
7.4 Neurological Diagnostic Equipment 103
7.4.1 Neurological Diagnostic Equipment: List of Pipeline Products 103
7.4.2 Neurological Diagnostic Equipment - Profiles of Key Pipeline Products 105
7.5 Neurosurgical Products 106
7.5.1 Neurosurgical Products - List of Pipeline Products 106
7.5.2 Neurosurgical Products - Profiles of Key Pipeline Products 106
7.6 CSF Management 107
7.6.1 CSF Management - List of Pipeline Products 107
7.6.2 CSF Management - Profiles of Key Pipeline Products 107

8 Global Neurology Devices Market - Consolidation Landscape 108
8.1 Deals by Count, 2007-2010 108
8.2 Key Deals in 2007-2010 110
8.2.1 Johnson & Johnson Completes Acquisition of Micrus Endovascular 110
8.2.2 Covidien Completes Acquisition Of ev3 for $2.6 Billion 111
8.2.3 Medtronic Acquired NDI Medical 112

9 Appendix 113
9.1 Definitions 113
9.1.1 Neurology Devices 113
9.1.2 CSF Management 113
9.1.3 Interventional Neurology 113
9.1.4 Neurological Diagnostic Equipment 114
9.1.5 Neurostimulation Devices 114
9.1.6 Neurosurgical Products 115
9.2 Acronyms 115
9.3 Research Methodology 116
9.3.1 Secondary Research 116
9.3.2 Primary Research 117
9.3.3 Modeling and Forecasting 117
9.4 Contact Us 117
9.5 Disclaimer 117
9.6 Sources 118

List of Tables


Table 1: Neurology Devices Market, Global, Revenue ($m), 20032010 11
Table 2: Neurology Devices Market, Global, Revenue ($m), 20102017 12
Table 3: Neurology Devices Market, Global, Key Company Revenues ($m), 2010 19
Table 4: CSF Management Market, Global, Revenue ($m), 20032010 21
Table 5: CSF Management Market, Global, Revenue ($m), 20102017 22
Table 6: CSF Management Market, Global, Key Company Revenues ($m), 2010 25
Table 7: Neurosurgical Products Market, Global, Revenue ($m), 20032010 26
Table 8: Neurosurgical Products Market, Global, Revenue ($m), 20102017 27
Table 9: Neurosurgical Products Market, Global, Key Company Revenues ($m), 2010 30
Table 10: Neurostimulation Devices Market, Global, Revenue ($m), 20032010 32
Table 11: Neurostimulation Devices Market, Global, Revenue ($m), 20102017 33
Table 12: Neurostimulation Devices Market, Global, Key Company Revenues ($m), 2010 40
Table 13: Interventional Neurology Market, Global, Revenue ($m), 20032010 42
Table 14: Interventional Neurology Market, Global, Revenue ($m), 20102017 43
Table 15: Interventional Neurology Market, Global, Key Company Revenues ($m), 2010 46
Table 16: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 20032010 47
Table 17: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 20102017 48
Table 18: Neurological Diagnostic Equipment Market, Global, Key Company Revenues ($m), 2010 51
Table 19: Neurology Devices Market, Cross Country Analysis, Global, CAGR (%), 20032017 52
Table 20: Neurology Devices Market, the US, Revenue ($m), 20032010 53
Table 21: Neurology Devices Market, the US, Revenue ($m), 20102017 54
Table 22: Neurology Devices Market, Canada, Revenue ($m), 20032010 55
Table 23: Neurology Devices Market, Canada, Revenue ($m), 20102017 56
Table 24: Neurology Devices Market, the UK, Revenue ($m), 20032010 57
Table 25: Neurology Devices Market, the UK, Revenue ($m), 20102017 58
Table 26: Neurology Devices Market, Germany, Revenue ($m), 20032010 59
Table 27: Neurology Devices Market, Germany, Revenue ($m), 20102017 60
Table 28: Neurology Devices Market, France, Revenue ($m), 20032010 61
Table 29: Neurology Devices Market, France, Revenue ($m), 20102017 62
Table 30: Neurology Devices Market, Italy, Revenue ($m), 20032010 63
Table 31: Neurology Devices Market, Italy, Revenue ($m), 20102017 64
Table 32: Neurology Devices Market, Spain, Revenue ($m), 20032010 65
Table 33: Neurology Devices Market, Spain, Revenue ($m), 20102017 66
Table 34: Neurology Devices Market, Japan, Revenue ($m), 20032010 67
Table 35: Neurology Devices Market, Japan, Revenue ($m), 20102017 68
Table 36: Neurology Devices Market, China, Revenue ($m), 20032010 69
Table 37: Neurology Devices Market, China, Revenue ($m), 20102017 70
Table 38: Neurology Devices Market, India, Revenue ($m), 20032010 71
Table 39: Neurology Devices Market, India, Revenue ($m), 20102017 72
Table 40: Neurology Devices Market, Australia, Revenue ($m), 20032010 73
Table 41: Neurology Devices Market, Australia, Revenue ($m), 20102017 74
Table 42: Neurology Devices Market, Brazil, Revenue ($m), 20032010 75
Table 43: Neurology Devices Market, Brazil, Revenue ($m), 20102017 76
Table 44: Neurology Devices: Pipeline Products Summary, 2011 92
Table 45: Neurostimulation Devices: List of Pipeline Products-1, 2011 93
Table 46: Neurostimulation Devices: List of Pipeline Products-2, 2011 94
Table 47: Neurostimulation Devices: List of Pipeline Products-3, 2011 95
Table 48: Neurostimulation Devices: List of Pipeline Products-4, 2011 96
Table 49: Neurostimulation Devices: List of Pipeline Products, 5, 2011 97
Table 50: Interventional Neurology: List of Pipeline Products, 1, 2011 100
Table 51: Interventional Neurology: List of Pipeline Products, 1, 2011 101
Table 52: Neurological Diagnostic Equipment: List of Pipeline Products, 1, 2011 103
Table 53: Neurological Diagnostic Equipment: List of Pipeline Products, 2, 2011 104
Table 54: Neurosurgical Products: List of Pipeline Products, 2011 106
Table 55: CSF Management: List of Pipeline Products, 2011 107
Table 56: Neurology Devices Market, Mergers & Acquisitions, by Volume Global, 2007-2010 108
Table 57: Neurology Devices Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 109
Table 58: Neurology Devices Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 110

List of Figures


Figure 1: Neurology Devices Market, Global, Revenue ($m), 20032010 11
Figure 2: Neurology Devices Market, Global, Revenue ($m), 20102017 12
Figure 3: Neurology Devices Market Dynamics 15
Figure 4: Neurology Devices Market, Global, Company Share (%), 2010 19
Figure 5: Neurology Devices Market Categorization and Segmentation 20
Figure 6: CSF Management Market, Global, Revenue ($m), 20032010 21
Figure 7: CSF Management Market, Global, Revenue ($m), 20102017 22
Figure 8: CSF Management, Market Dynamics 23
Figure 9: CSF Management Market, Global, Company Share (%), 2010 25
Figure 10: Neurosurgical Products Market, Global, Revenue ($m), 20032010 26
Figure 11: Neurosurgical Products Market, Global, Revenue ($m), 20102017 27
Figure 12: Neurosurgical Products Market Dynamics 28
Figure 13: Neurosurgical Products Market, Global, Company Share (%), 2010 30
Figure 14: Neurostimulation Devices Market, Global, Revenue ($m), 20032010 32
Figure 15: Neurostimulation Devices Market, Global, Revenue ($m), 20102017 33
Figure 16: Neurostimulation Devices Market Dynamics 34
Figure 17: Potential of Neurostimulation Devices for the Treatment of Various Indications, 2010 35
Figure 18: Neurology Devices, Global, Number of Pipeline Products, 2011 36
Figure 19: Neurostimulation Devices Market, Global, Company Shares (%), 2010 40
Figure 20: Interventional Neurology Market, Global, Revenue ($m), 20032010 42
Figure 21: Interventional Neurology Market, Global, Revenue ($m), 20102017 43
Figure 22: Interventional Neurology, Market Dynamics 44
Figure 23: Interventional Neurology Market, Global, Company Shares (%), 2010 46
Figure 24: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 20032010 47
Figure 25: Neurological Diagnostic Equipment Market, Global, Revenue ($m), 20102017 48
Figure 26: Neurological Diagnostic Equipment, Market Dynamics 49
Figure 27: Neurological Diagnostic Equipment Market, Global, Company Shares (%), 2010 51
Figure 28: Neurology Devices Market, Cross Country Analysis, Global, CAGR (%), 20032017 52
Figure 29: Neurology Devices Market, the US, Revenue ($m), 20032010 53
Figure 30: Neurology Devices Market, the US, Revenue ($m), 20102017 54
Figure 31: Neurology Devices Market, Canada, Revenue ($m), 20032010 55
Figure 32: Neurology Devices Market, Canada, Revenue ($m), 20102017 56
Figure 33: Neurology Devices Market, the UK, Revenue ($m), 20032010 57
Figure 34: Neurology Devices Market, the UK, Revenue ($m), 20102017 58
Figure 35: Neurology Devices Market, Germany, Revenue ($m), 20032010 59
Figure 36: Neurology Devices Market, Germany, Revenue ($m), 20102017 60
Figure 37: Neurology Devices Market, France, Revenue ($m), 20032010 61
Figure 38: Neurology Devices Market, France, Revenue ($m), 20102017 62
Figure 39: Neurology Devices Market, Italy, Revenue ($m), 20032010 63
Figure 40: Neurology Devices Market, Italy, Revenue ($m), 20102017 64
Figure 41: Neurology Devices Market, Spain, Revenue ($m), 20032010 65
Figure 42: Neurology Devices Market, Spain, Revenue ($m), 20102017 66
Figure 43: Neurology Devices Market, Japan, Revenue ($m), 20032010 67
Figure 44: Neurology Devices Market, Japan, Revenue ($m), 20102017 68
Figure 45: Neurology Devices Market, China, Revenue ($m), 20032010 69
Figure 46: Neurology Devices Market, China, Revenue ($m), 20102017 70
Figure 47: Neurology Devices Market, India, Revenue ($m), 20032010 71
Figure 48: Neurology Devices Market, India, Revenue ($m), 20102017 72
Figure 49: Neurology Devices Market, Australia, Revenue ($m), 20032010 73
Figure 50: Neurology Devices Market, Australia, Revenue ($m), 20102017 74
Figure 51: Neurology Devices Market, Brazil, Revenue ($m), 20032010 75
Figure 52: Neurology Devices Market, Brazil, Revenue ($m), 20102017 76
Figure 53: Neurology Devices Market Opportunities and Risk Evaluation, Global, by Segment 77
Figure 54: Neurology Devices, Competitive Assessment, 2011 79
Figure 55: Medtronic, Inc, SWOT Analysis, Neurology Devices, Global, 2010 81
Figure 56:Boston Scientific Corporation, SWOT Analysis, Neurology Devices, Global, 2010 83
Figure 57: St. Jude Medical, Inc, SWOT Analysis, Neurology Devices, Global, 2010 85
Figure 58: Integra LifeSciences Holdings Corporation, SWOT Analysis, Neurology Devices, Global, 2010 88
Figure 59: B. Braun Melsungen AG, SWOT Analysis, Neurology Devices, Global, 2010 89
Figure 60: Cadwell Laboratories, Inc, SWOT Analysis, Neurology Devices, Global, 2010 91
Figure 61: Neurology Devices: Pipeline Products Summary, 2011 92
Figure 62: Neurology Devices Market, Mergers & Acquisitions, by Volume, Global, 2007-2010 108

Upcoming Reports:

Energy Conservation And Efficiency Market - Global Industry Analysis, Size, Share, Trends, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Energy conservation is reduction in amount of energy consumed, whereas energy efficiency is using less energy for any constant service. Both are energy reduction techniques. Energy conservation results in increased environmental quality, personal financing security and national security. The Energy efficiency markets distributes goods and services which reduces energy used to fuel our economies.  The concern regarding carbon emissions and increase in consumption of power has demanded for energy efficient systems. Manufacturing industries are one of the major consumers of...
Poland: crushed stone, gravel and pebbles market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the gravel and pebbles market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the gravel and pebbles market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate...
2,5-Dichloroaniline Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
2,5 dichloroaniline, also known as m-Dichloroaniline and 3,5-Dichlorobenzenamine is a brown to white solid which has melting point 50oC to 53oC and boiling point 261oC. It is soluble in most organic solvents but insoluble in water. It is an amine which is used as an intermediate in the production of many products that include azo dyes, agricultural chemicals, pigments and pharmaceuticals among others. Aromatic amines are weaker bases than aliphatic. The most important aromatic amine is aniline, an amine (primary) which gets replaced with an amino group in the place of hydrogen...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...